Outcome
    Moderate Evidence
    Effectiveness 3/5

    Ashwagandha for Adrenal Function Support

    Ashwagandha is the best-supported adaptogen for stress-related cortisol patterns, though trials are small, short and often industry-funded.

    Overview

    Adrenal function support is a phrase worth unpacking before anything else. Adrenal fatigue is not a recognised medical diagnosis, and ashwagandha does not repair a failing adrenal gland. What the randomised evidence actually shows is that it lowers serum cortisol and perceived stress scores in chronically stressed but otherwise healthy adults. That is a real and reasonably well-replicated finding across multiple randomised trials and meta-analyses, typically using 240 to 600 mg daily of a standardised root extract for eight to twelve weeks. Effect sizes on stress scales are moderate, and cortisol reductions in the range of 20 to 30 percent have been reported. Genuine adrenal insufficiency is a serious endocrine condition that requires diagnosis and hormone replacement, not a herb.

    Verdict

    Likely effective

    Multiple randomised trials and recent meta-analyses report reduced serum cortisol and lower perceived stress and anxiety scores with standardised root extract over 8-12 weeks. Trials are small and often industry-funded.

    How It Works

    Ashwagandha appears to act on the hypothalamic-pituitary-adrenal axis upstream of the adrenal gland rather than on the gland itself. Withanolides modulate GABA-A signalling and reduce central drive to the axis, which lowers ACTH-stimulated cortisol output; this is the mechanism consistent with the observed fall in morning serum cortisol without any sign of adrenal suppression. Secondary effects include antioxidant activity, reduced inflammatory cytokine signalling and modest thyroid hormone elevation. The thyroid effect is small in healthy people but relevant to anyone with existing thyroid disease, and it is the main reason this herb is not neutral for everyone.

    Pathways involved

    HPA axis downregulation
    GABA-A receptor modulation
    Reduced ACTH-driven cortisol output
    Antioxidant and anti-inflammatory activity
    Modest thyroid hormone elevation

    Dosing & Protocol

    The best-studied regimens use standardised root extract at 300 mg twice daily, or 240 to 600 mg once daily, for eight to twelve weeks. Extract standardisation matters more than raw milligrams, since withanolide content varies widely between products. Root extract is the studied material. Leaf-containing products have a different withanolide profile and have been implicated in most reported liver injury cases. Sedation is dose-related, which is why many people prefer the larger dose in the evening.
    ScenarioDoseFormTiming
    Most common trial regimen300 mg twice dailyStandardised root extract (about 5% withanolides)Morning and evening, with food
    Single daily dose240-600 mg dailyStandardised root extractEvening, with food
    Sleep-weighted use300 mgStandardised root extract1-2 hours before bed
    Trial duration8-12 weeksAnyReassess and consider a break after 12 weeks
    1. 1

      Choose root-only standardised extract· Before starting

      Look for root extract with a stated withanolide percentage. Avoid leaf-containing products.

    2. 2

      Start at 300 mg in the evening· Week 1

      Taking the first dose at night limits daytime drowsiness while you gauge sensitivity.

    3. 3

      Add a morning dose if needed· Week 2 onward

      Move to 300 mg twice daily with food if the evening dose is well tolerated.

    4. 4

      Track stress, sleep and energy weekly· Weeks 1-12

      Perceived stress and sleep quality are the endpoints trials moved; write them down rather than relying on recall.

    5. 5

      Reassess at twelve weeks· Week 12

      Long-term safety data beyond three months are limited, so review continued use with a clinician.

    Evidence

    The linked evidence includes a 2024 randomised controlled trial of Withania somnifera extract in chronically stressed adults and two 2024 meta-analyses covering stress, anxiety and insomnia outcomes. The direction of effect is consistent: lower perceived stress scores, lower serum cortisol and improved sleep quality relative to placebo over eight to twelve weeks. The limitations are equally consistent. Trials are small, frequently funded by extract manufacturers, use different proprietary extracts that are not interchangeable, and rarely run beyond twelve weeks. None of them measured adrenal function in any clinical sense; cortisol is a biomarker, not a diagnosis. That combination supports a likely verdict rather than a strong one.
    Best available evidence
    Randomised placebo-controlled trials and 2024 meta-analyses
    Typical effect
    Moderate reduction in perceived stress scores; roughly 20-30% lower serum cortisol in some trials
    Studied dose
    240-600 mg daily standardised root extract
    Time to effect
    4-8 weeks, with most endpoints measured at 8-12 weeks
    Certainty of evidence
    Moderate for stress and cortisol; none for treating adrenal insufficiency

    A 2024 randomised controlled trial in chronically stressed adults and two 2024 systematic reviews with meta-analysis covering stress, anxiety and insomnia outcomes.

    Effects of Withania somnifera Extract in Chronically Stressed Adults: A Randomized Controlled Trial

    Score: 6/10
    2024
    rct

    Withania somnifera extract improved stress and fatigue measures in chronically stressed adults.

    View source

    Effects of Ashwagandha (Withania Somnifera) on stress and anxiety: A systematic review and meta-analysis

    Score: 7/10
    2024
    meta_analysis
    n=558

    Arumugam V, et al.

    Ashwagandha formulations have beneficial effects on stress and anxiety.

    View source

    Safety and efficacy of Withania somnifera for anxiety and insomnia: Systematic review and meta-analysis

    Score: 8/10
    2024
    meta_analysis
    n=254

    Fatima K, et al.

    Pooled results from five RCTs (n = 254) demonstrated that W. somnifera significantly reduced HAM-A scores, as well as sleep parameters such as SOL, TST, PSQI, and SE, but not WASO and TIB.

    View source

    Safety

    Common effects are mild: drowsiness, stomach upset and loose stools, mostly dose-related and mostly early. The serious concern is hepatotoxicity. Regulatory authorities in several countries have reviewed clusters of liver injury cases associated with ashwagandha, generally involving leaf-containing or poorly characterised products, presenting as jaundice, dark urine and marked fatigue weeks into use. It should be avoided in pregnancy, where traditional use includes abortifacient reports, and during breastfeeding. People with autoimmune thyroid disease, hyperthyroidism or on thyroid replacement need clinician oversight because of the thyroid hormone effect, and anyone with existing liver disease should not take it. Stop immediately and seek assessment if jaundice or unexplained fatigue develops.

    Adrenal insufficiency is a medical emergency, not a supplement target

    Persistent fatigue with weight loss, dizziness on standing, salt craving or skin darkening needs endocrine testing. Do not self-treat suspected adrenal disease with a herb.

    Interactions & Conflicts

    Interacts withSeverityMechanismAction
    Thyroid hormone replacement
    moderate
    		Ashwagandha can raise T3 and T4, risking over-replacementMonitor thyroid function; adjust dose only with a clinician
    Sedatives, benzodiazepines and alcohol
    moderate
    		Additive central depressant effect via GABA-A modulationAvoid combining or reduce the evening dose
    Immunosuppressants
    moderate
    		Immunostimulant activity may oppose the drug effectAvoid unless cleared by the prescribing team
    Hepatotoxic drugs and existing liver disease
    high
    		Reported cases of drug-induced liver injuryAvoid; seek assessment if jaundice or dark urine occurs
    Antidiabetic and antihypertensive medication
    low
    		May modestly lower blood glucose and blood pressureMonitor readings when starting

    References

    1. Effects of Withania somnifera extract in chronically stressed adults: a randomized controlled trial. Nutrients. 2024
    2. Effects of ashwagandha on stress and anxiety: a systematic review and meta-analysis. Explore (NY). 2024
    3. Safety and efficacy of Withania somnifera for anxiety and insomnia: systematic review and meta-analysis. Hum Psychopharmacol. 2024

    Frequently Asked Questions

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.